The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $66.06

Today's change-0.26 -0.39%
Updated May 26 4:02 PM EDT. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $66.06

Today's change-0.26 -0.39%
Updated May 26 4:02 PM EDT. Delayed by at least 15 minutes.

AbbVie Inc crosses below 20-day moving average

AbbVie Inc closed lower Friday, dropping (U.S.)$0.26 or 0.39% to (U.S.)$66.06 and crossing below its 20-day moving average. Over the last five days, shares have gained 0.73% and are currently 3.03% off of the 52-week high. Shares have underperformed the S&P 500 by 8.86% during the last year.

Key company metrics

  • Open(U.S.) $66.14
  • Previous close(U.S.) $66.32
  • High(U.S.) $66.41
  • Low(U.S.) $65.85
  • Bid / Ask-- / --
  • YTD % change+5.49%
  • Volume4,083,006
  • Average volume (10-day)6,184,616
  • Average volume (1-month)5,618,199
  • Average volume (3-month)6,175,970
  • 52-week range(U.S.) $55.06 to (U.S.) $68.12
  • Beta1.54
  • Trailing P/E17.01×
  • P/E 1 year forward11.96×
  • Forward PEG0.83×
  • Indicated annual dividend(U.S.) $2.56
  • Dividend yield3.88%
  • Trailing EPS(U.S.) $3.88
Updated May 26 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.04%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue6,5386,7966,4326,452
Total other revenue--------
Total revenue6,5386,7966,4326,452
Gross profit4,9055,2444,9245,029
Total cost of revenue1,6331,5521,5081,423
Total operating expense4,1194,4384,0714,065
Selling / general / administrative1,3681,6531,3811,466
Research & development1,1351,1901,1061,124
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0408070
Other operating expenses, total--------
Operating income2,4192,3582,3612,387
Interest income (expense), net non-operating-273-316-271-245
Gain (loss) on sale of assets--------
Other--------
Income before tax2,0861,9982,0142,096
Income after tax1,7111,3911,5981,610
Income tax, total375607416486
Net income1,7111,3911,5981,610
Total adjustments to net income--------
Net income before extra. items1,7111,3911,5981,610
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,7111,3911,5981,610
Inc. avail. to common incl. extra. items1,7111,3911,5981,610
Diluted net income1,7111,3911,5981,610
Dilution adjustment--------
Diluted weighted average shares1,6031,6251,6401,632
Diluted EPS excluding extraordinary itemsvalue per share1.070.860.970.99
Dividends per sharevalue per share0.640.570.570.57
Diluted normalized EPSvalue per share1.070.881.021.03